Biotransformation of bufadienolides by cell suspension cultures of Saussurea involucrata

Phytochemistry

Volumn 72, Issue 14-15, 2011, Pages 1779-1785

  Zhang, Xing ^a,d   Ye, Min ^a   Dong, Yin Hui ^b   Hu, Hong Bo ^b   Tao, Si Jia ^c   Yin, Jun ^d   Guo, De An ^a,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Asterates; Biotransformation; Bufadienolides; Cell suspension culture; Cytotoxicity; Saussurea involucrata

Indexed keywords

BUFADIENOLIDE DERIVATIVE; CARDIOTONIC AGENT;

ARTICLE; BIOTRANSFORMATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECT; FEMALE; HUMAN; MASS SPECTROMETRY; MEDICINAL PLANT; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SAUSSUREA; TIME; TUMOR CELL LINE;

BIOTRANSFORMATION; BUFANOLIDES; CARDIOTONIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; SAUSSUREA; TIME FACTORS;

SAUSSUREA; SAUSSUREA INVOLUCRATA;

EID: 80051552981     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2011.05.004     Document Type: Article

References (29)

1. M.C. Alley, D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, R.H. Shoemaker, and M.R. Boyd Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay Cancer Res. 48 1988 589 601 (Pubitemid 18056527)
2. R.D. Chen, J.H. Zou, J.M. Jia, and J.G. Dai Isolation and analysis of syringin in cell suspension cultures of Saussurea involucrata Acta Pharmacol. Sin. 44 2009 436 439
3. G.A. Cunha Filho, I.S. Resck, B.C. Cavalcanti, C.O. Pessoa, M.O. Moraes, J.R.O. Ferreira, F.A.R. Rodrigues, and M.L. Dos Santos Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion Toxicon 56 2010 339 348
4. D. Daniel, C. Susal, B. Kopp, G. Opelz, and P. Terness Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives Int. Immunopharmacol. 3 2003 1791 1801 (Pubitemid 37421264)
5. P.J. Hilton, W. McKinnon, E.C. Gravett, J.M.R. Peron, C.M. Frampton, M.G. Nicholls, and G. Lord Selective inhibition of the cellular sodium pump by emicymarin and 14ss anhydroxy bufadienolides Steroids 75 2010 1137 1145
6. A. Inada, T. Nakanishl, H. Nishino, E. Ichiishi, T. Mukainaka, M. Okuda, and H. Tokuda Inhibitory effects of bufadienolides on Epstein-Barr virus early antigen activation and on growth of mouse skin and mouse pulmonary tumors Nat. Med. 53 1999 324 328 (Pubitemid 30074974)
7. Y. Kamano, and G.R. Pettit Bufadienolides. 26. Synthesis of scillarenin J. Org. Chem. 39 1974 2629 2631
8. Kamano, Y., Inoue, M., Pettit, G.R., Satoh, H., Tozawa, M., 1979. Synthesis of some natural bufadienolides and their stereoisomers. Koen Yoshishu-Tennen Yuki Kagobutsu Toronkai 22, pp. 33-39.
9. Y. Kamano, A. Yamashita, T. Nogawa, H. Morita, K. Takeya, H. Itokawa, T. Segawa, A. Yukita, K. Saito, M. Katsuyama, and G.R. Pettit QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5 J. Med. Chem. 45 2002 5440 5447 (Pubitemid 35424962)
10. F. Li, Y. Weng, L.H. Wang, H.B. He, J.Y. Yang, and X. Tang The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers Int. J. Pharm. 393 2010 203 212
11. H.H.A. Linde, and F. Loehrer Toad toxins. 43. Structure of gamabufotalininol (1) Pharm. Acta Helv. 66 1991 98 101
12. X.C. Ma, J. Cui, J. Zheng, and D.A. Guo Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat J. Mol. Catal. B Enzym. 48 2007 42 50 (Pubitemid 47126969)
13. X.C. Ma, J. Zheng, and D.A. Guo Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani Enzyme Microb. Technol. 40 2007 1585 1591 (Pubitemid 46482647)
14. 13C NMR chemical shifts of four bufadienolides by 2D NMR spectroscopy Magn. Reson. Chem. 33 1995 312 314
15. Y. Simeo, and J.V. Sinisterra Biotransformation of terpenoids: a green alternative for producing molecules with pharmacological activity Mini Rev. Org. Chem. 6 2009 128 134
16. A.B. Soliev, S.Y. Mirzaakhmedov, M.S. Tashmukhamedov, F.G. Kamaev, S.I. Salikhov, N.I. Zakirova, A.Y. Abramov, I.V. Usanova, V.N. Syrov, and Z.A. Khushbaktova Chemical composition and biological activity of total bufadienolides from the Central-Asian Bufo viridis toad venom Pharm. Chem. J. 41 2007 600 604
17. J.Y. Wang, Y. Jin, Z.Y. Xu, Z. Zheng, and S. Wan Involvement of caspase-3 activity and survivin downregulation in cinobufocini-induced apoptosis in A 549 cells Exp. Biol. Med. 234 2009 566 572
18. R. Verpoorte, Q.K. Phan, and S.A. Baerheim Chemical constituents of Vietnamese toad venom, collected from Bufo melanostictus Schneider. Part II. The bufadienolides J. Nat. Prod. 43 1980 347 352 (Pubitemid 11232916)
19. M. Ye, J.G. Dai, H.Z. Guo, Y.J. Cui, and D.A. Guo Glucosylation of cinobufagin by cultured suspension cells of Catharanthus roseus Tetrahedron Lett. 43 2002 8535 8538 (Pubitemid 35232663)
20. M. Ye, J. Han, H.Z. Guo, and D.A. Guo Structural determination and complete NMR spectral assignments of a new bufadienolide glycoside Magn. Reson. Chem. 40 2002 786 788 (Pubitemid 37281988)
21. M. Ye, L.L. Ning, J.X. Zhan, H.Z. Guo, and D.A. Guo Biotransformation of cinobufagin by cell suspension cultures of Catharanthus roseus and Platycodon grandiflorum J. Mol. Catal. B Enzym. 22 2003 89 95 (Pubitemid 36299207)
22. M. Ye, G.Q. Qu, H.Z. Guo, and D.A. Guo Specific 12β-hydroxylation of cinobufagin by filamentous fungi Appl. Environ. Microbiol. 70 2004 3521 3527 (Pubitemid 38745899)
23. M. Ye, G.Q. Qu, H.Z. Guo, and D.A. Guo Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships J. Steroid Biochem. Mol. Biol. 91 2004 87 98 (Pubitemid 38903187)
24. M. Ye, J. Han, G.Z. Tu, D.G. An, and D.A. Guo Microbial hydroxylation of bufalin by Cunninghamella blakesleana and Mucor spinosus J. Nat. Prod. 68 2005 626 628 (Pubitemid 40586336)
25. M. Ye, J. Han, D.G. An, G.Z. Tu, and D.A. Guo New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus Tetrahedron 61 2005 8947 8955 (Pubitemid 41133272)
26. M. Ye, and D.A. Guo Substrate specificity for the 12β-hydroxylation of bufadienolides by Alternaria alternata J. Biotechnol. 117 2005 253 262 (Pubitemid 40615568)
27. C.H. Yu, S.F. Kan, H.F. Pu, E.J. Chien, and P.S. Wang Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells Cancer Sci. 99 2008 2467 2476
28. J. Zhang, Y. Sun, J.H. Liu, B.Y. Yu, and Q. Xu Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR) Bioorg. Med. Chem. Lett. 17 2007 6062 6065 (Pubitemid 47552850)
29. J. Zhao, S.H. Guan, X.B. Chen, W. Wang, M. Ye, and D.A. Guo Two new compounds derived from bufalin Chin. Chem. Lett. 18 2007 1316 1318